- Case report
- Open Access
Isolated angiitis of the central nervous system with tumor-like lesion, mimicking brain malignant glioma: a case report and review of the literature
© You et al; licensee BioMed Central Ltd. 2011
- Received: 18 May 2011
- Accepted: 26 August 2011
- Published: 26 August 2011
Isolated angiitis of the central nervous system (IACNS) is a rare but severe vascular disease, which could present like an isolated inflammatory lesion on magnetic resonance imaging (MRI). To date, only a few such cases with tumor-like IACNS have been reported.
A 35-year-old woman presented with headache and left-sided weakness. MRI scans initially mislead us to a diagnosis of glioblastoma (GBM). Surgery was performed. The mass was sub-totally resected. Pathological examination confirmed a cerebral vasculitis. Radiological features, such as disproportionate mass effect, striped hemorrhage and abnormal enhancement of adjacent vessels, could be helpful to distinguish a tumor-like IACNS from a GBM. Single therapy with high doses of steroid did not improve the patient's condition. Combined therapy with prednisolone and cyclophosphamide showed great benefit to the patient. No relapse occurred during the period of 18 months follow-up.
Although a tumor-like IACNS has no established imaging features, a diagnosis of tumor-like IACNS should be suspected when MRI shows inappropriate presentations of a tumor. Greater awareness of this potential manifestation of IACNS may facilitate more prompt diagnosis and treatment.
- primary angiitis
- tumor-like lesion
Isolated angiitis of the central nervous systmen (IACNS) represents a rare and poorly understood form of vascular inflammatory disease restricted to the brain and spinal cord. An average annual incidence rate of 2.4 cases per 1,000,000 person-years was found by a report from US . Histopathology usually reveals granulomatous inflammation affecting arterioles and small arteries of the parenchyma and/or leptomeninges . Non-specific clinical manifestations and various imaging findings often lead to an incorrect or delayed diagnosis and treatment , particularly for an extremely rare form of tumor-like lesion. In this report, we describe a woman with tumor-like IACNS that was initially mistaken for glioblastoma (GBM).
IACNS, which was first reported as early as 1952 , can occur mostly when patients are 30 to 50 years old . To date, a few such cases with tumor-like IACNS have been reported. Its etiology and pathogenesis are still unknown. It is very possible that viral infections initiate the inflammatory process that somehow becomes self-sustaining . It is also speculated that there may be a genetic predisposition in certain individuals leading to an enhanced risk of a vasculitic process when there is an exposure to a particular antigen that "sets off" the immune system .
Clinical onset of IACNS is usually subacute, but it can have acute onset with rapid progress within a few days or weeks. The most frequent clinical manifestations at presentation are headache, altered cognition, hemiparesis or persistent neurological deficit or stroke . Subarachnoid hemorrhage could be the first presentation of IACNS . Less common complaints are aphasia, transient ischemic attack, ataxia, dysphasia, nausea or vomiting, loss of memory, seizure disorder, dyslalia, hypomnesia and paralysis. Interestingly, there have been so far two case studies reporting psychiatric symptoms in two patients with IACNS [8, 9]. But all the symptoms above-mentioned are non-specific for diagnosis.
With regard to imaging characteristics, IACNS always presents a challenge in radiographic diagnosis. Its MRI findings are highly variable, ranging from multiple irregular white matter changes to intracerebral hemorrhages [7, 10]. The present case demonstrated a large monofocal lesion with disproportionate mass effect, striped hemorrhage, and abnormal enhancement of adjacent vessels (Figure 2d) on MRI. Possibly some main artery and its branches were involved. So, given a tumor-like lesion with these characteristics on neuroimages, we suggest an IACNS should be considered in the differential diagnosis. This would be an important lesson learnt from this case. Several studies [3, 11, 12] to some extent emphasized the similar viewpoints. In addition, Campi et al.  indicated that VRPVS (dilatation of Virchow-Robin perivascular spaces), which signify severe but reversible perivascular inflammation causing blood-brain barrier disruption and injury of surrounding white matter, might likely be specific for vasculitis. Unfortunately, this did not show up in this case.
Moore  recommended a widely received standard for the diagnosis of IACNS in which he emphasized the importance of cerebral angiography and biopsy based on careful exclusion of other diseases. When cerebral angiography shows stenosis or occlusion of the cerebral vessels, brain biopsy should be performed . However, the classic appearance of alternating narrowing and dilatation is not completely specific and has been observed in only 25% of patients with IACNS; the angiogram is normal in up to 40% of pathologically documented cases . It should be individualized to make a differential diagnosis [3, 14, 17]. IACNS may clinically mimic encephalitis, multiple sclerosis, acute disseminated encephalomyelitis, myelinoclastic diffuse sclerosis, cerebral infarction, leukoencephalopathy or other brain tumors, when they present isolated lesions on MRI. It may be difficult to differentiate between IACNS and demyelinating or inflammatory diseases [18–20], because of similar symptoms, clinical exam and laboratory findings. Besides, it is also not easy to differentiate between IACNS and lymphoma when there are multiple-enhancing lesions with vasogenic edema on neuroimagines. Against the above, only biopsy allows a definite diagnosis. But sometimes, a single isolated negative biopsy does not necessarily exclude IACNS [21, 22] or secondary CNS vasculitis. In that case, empirical treatment should be administrated.
No clinical trials have been performed in patients with IACNS, nor is it possible to draw firm conclusions from the current study because of the non-standardized nature of the treatment protocols used in these cases. Fountain et al.  reported a case with IACNS controlled by cyclophosphamide alone, while Carandang C and Grant A reported a female patient with IACNS responding to steroids alone . But Barron et al.  indicated that steroid therapy alone failed to improve the condition. This finding is consistent with ours. Others recommended combination therapy consisting of prednisone and cyclophosphamide for at least 1 year [25, 26]. In addition, Salvarani et al.  indicated that patients with IACNS which also have vascular deposits of β-peptide generally respond well to immunosuppressive treatment. However, the present case demonstrated good effects of immunosuppressant to patient without indication of amyloid protein deposition. Currently, most authors consent to combined and long-term therapy in treating IACNS. It is strongly suggested [1, 28] that immunosuppressive therapy should be judiciously employed in patients with IACNS, based on the clinical features (any co-morbid conditions, the potential for neurological recovery, et al). In our case, the initial pulse therapy with steroid failed to prevent the rapid progress of vasculitis. Only combined therapy with cyclophosphamide improved her condition dramatically.
The prognosis of IACNS varies greatly and could be from months to years [1, 11, 17]. Untreated IACNS usually causes fatal outcome. Greater awareness of these potential manifestations of IACNS may facilitate more accurate diagnosis and prompt treatment.
In conclusion, we suggest that correct diagnosis and appropriate treatment of tumor-like IACNS should be essential for prognosis. When the MRI shows a tumor-like subcortical lesion with disproportionate mass effect, and/or striped hemorrhage and/or abnormal enhancement of adjacent vessels, an IACNS should be include in the differential diagnosis. When high doses of steroids show no effect to the patient with tumor-like IACNS, combined treatment with cyclophosphamide followed by long term oral therapy is recommended.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Salvarani C, Brown RD, Calamia KT, Christianson TJ, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J, Hunder GG: Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol. 2007, 62: 442-451. 10.1002/ana.21226.View ArticlePubMedGoogle Scholar
- MacLaren K, Gillespie J, Shrestha S, Neary D, Ballardie FW: Primary angiitis of the central nervous system: emerging variants. Q J Med. 2005, 98: 643-654.View ArticleGoogle Scholar
- Markus K, Peter B: Primary central nervous system vasculitis: clinical experiences with 21 new European cases. Rheumatol Int. 2009, 31: 463-472.Google Scholar
- Newman W, Wolf A: Non-infectious granulomatous angiitis involving the central nervous system. Trans Am Neurol Assoc. 1952, 56: 114-117.PubMedGoogle Scholar
- Iwase T, Ojika K, Mitake S, Katada E, Katano H, Mase M, Yoshida S, Ueda R: Involvement of CD45RO+ T lymphocyte infiltration in a patient with primary angiitis of the central nervous system restricted to small vessels. Eur Neurol. 2001, 45: 184-185. 10.1159/000052120.View ArticlePubMedGoogle Scholar
- Kelley RE: CNS vasculitis. Front Biosci. 2004, 9: 946-955. 10.2741/1259.View ArticlePubMedGoogle Scholar
- Kumar R, Wijdicks EF, Brown RD, Parisi JE, Hammond CA: Isolated angiitis of the CNS presenting as subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1997, 62: 649-651. 10.1136/jnnp.62.6.649.PubMed CentralView ArticlePubMedGoogle Scholar
- Hocaoglu C, Tan M: Isolated angiitis of the central nervous system: a case presented with atypical psychiatric symptoms. Prog Neuropsychopharmacol Biol Psychiatry. 2005, 29: 627-631. 10.1016/j.pnpbp.2005.01.015.View ArticlePubMedGoogle Scholar
- Carandang C, Grant A: Delirium and Isolated Angiitis of the Central Nervous System: a Case Report and Review. CNS Spectrums. 2008, 13: 209-213.PubMedGoogle Scholar
- Ozawa T, Sasaki O, Sorimachi T, Tanaka R: Primary angiitis of the central nervous system: report of two cases and review of the literature. Neurosurgery. 1995, 36: 173-179. 10.1227/00006123-199501000-00023.View ArticlePubMedGoogle Scholar
- Lee Y, Kim JH, Kim E, Park SH, Yim YJ, Sohn CH, Chang KH: Tumor-mimicking primary angiitis of the central nervous system: initial and follow-up MR features. Neuroradiology. 2009, 51: 651-659. 10.1007/s00234-009-0546-3.View ArticlePubMedGoogle Scholar
- Ay H, Sahin G, Saatci I, Söylemezoğlu F, Saribaş O: Primary Angiitis of the Central Nervous System and Silent Cortical Hemorrhages. AJNR Am J Neuroradiol. 2002, 23: 1561-1563.PubMedGoogle Scholar
- Campi A, Benndorf G, Filippi M, Reganati P, Martinelli V, Terreni MR: Primary angiitis of the central nervous system: serial MRI of brain and spinal cord. Neuroradiology. 2001, 43: 599-607. 10.1007/s002340100561.View ArticlePubMedGoogle Scholar
- Moore PM: Diagnosis and management of isolated angiitis of the central nervous system. Neurology. 1989, 39: 167-173.View ArticlePubMedGoogle Scholar
- Younger DS: Vasculitis of the nervous system. Curr Opin Neurol. 2004, 17: 317-336. 10.1097/00019052-200406000-00014.View ArticlePubMedGoogle Scholar
- Calabrese LH, Furlan AJ, Gragg LA, Ropos TJ: Primary angiitis of the central nervous system: diagnostic criteria and clinical approach. Cleve Clin J Med. 1992, 59: 293-306.View ArticlePubMedGoogle Scholar
- Scolding NJ, Wilson H, Hohlfeld R, Polman C, Leite I, Gilhus N: The recognition, diagnosis and management of cerebral vasculitis: a European survey. Eur J Neurol. 2002, 9: 343-347. 10.1046/j.1468-1331.2002.00422.x.View ArticlePubMedGoogle Scholar
- Tan HM, Chan LL, Chuah KL, Goh NS, Tang KK: Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis. Br J Radiol. 2004, 77: 153-156. 10.1259/bjr/26682607.View ArticlePubMedGoogle Scholar
- Mandrioli J, Ficarra G, Callari G, Sola P, Merelli E: Monofocal acute large demyelinating lesion mimicking brain glioma. Neurol Sci. 2004, 25: S386-388. 10.1007/s10072-004-0349-6.View ArticlePubMedGoogle Scholar
- Engelter ST, Rueegg S, Kirsch EC, Fluri F, Probst A, Steck AJ, Lyrer PA: CADASIL mimicking primary angiitis of the central nervous system. Arch Neurol. 2002, 59: 1480-1483. 10.1001/archneur.59.9.1480.View ArticlePubMedGoogle Scholar
- Dawson TM, Starkebaum G: Isolated central nervous system vasculitis associated with hepatitis C infection. J Rheumatol. 1999, 26: 2273-2276.PubMedGoogle Scholar
- Alreshaid AA, Powers WJ: Prognosis of patients with suspected primary CNS angiitis and negative brain biopsy. Neurology. 2003, 61: 831-833.View ArticlePubMedGoogle Scholar
- Fountain NB, Lopes MB: Control of primary angiitis of the CNS associated with cerebral amyloid angiopathy by cyclophosphamide alone. Neurology. 1999, 52: 660-662.View ArticlePubMedGoogle Scholar
- Barron TF, Ostrov BE, Zimmerman RA, Packer RJ: Isolated angiitis of CNS: treatment with pulse cyclophosphamide. Pediatr Neurol. 1993, 9: 73-75. 10.1016/0887-8994(93)90017-7.View ArticlePubMedGoogle Scholar
- Guillevin L, Ramanoelina J, Mahr A: Central nervous system and systemic vasculitides. Rev Neurol (Paris). 2002, 158: 907-913.Google Scholar
- Kluck JJ, ter Berg JW, van der Laan RT, Krijne-Kubat B: Two patients with isolated vasculitis of the central nervous system. Ned Tijdschr Geneeskd. 2002, 146: 482-486.PubMedGoogle Scholar
- Salvarani C, Brown RD, Calamia KT, Christianson TJ, Huston J, Meschia JF, Giannini C, Miller DV, Hunder GG: Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. Rheumatology. 2008, 47: 1671-1677. 10.1093/rheumatology/ken328.View ArticlePubMedGoogle Scholar
- Molloy ES, Singhal AB, Calabrese LH: Tumour-like mass lesion: an under-recognised presentation of primary angiitis of the central nervous system. Ann Rheum Dis. 2008, 67: 1732-1735. 10.1136/ard.2008.096800.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.